BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1309 related articles for article (PubMed ID: 25857211)

  • 1. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
    Serhan CN; Chiang N; Dalli J
    Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-resolving lipid mediators are leads for resolution physiology.
    Serhan CN
    Nature; 2014 Jun; 510(7503):92-101. PubMed ID: 24899309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized pro-resolving lipid mediators in the inflammatory response: An update.
    Bannenberg G; Serhan CN
    Biochim Biophys Acta; 2010 Dec; 1801(12):1260-73. PubMed ID: 20708099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
    Serhan CN; Chiang N
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.
    Li QF; Hao H; Tu WS; Guo N; Zhou XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7442-7453. PubMed ID: 32706084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
    Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.
    Spite M; Serhan CN
    Circ Res; 2010 Nov; 107(10):1170-84. PubMed ID: 21071715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
    Nowak JZ
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
    Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
    Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.
    Serhan CN
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():44-8. PubMed ID: 19630766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
    López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J
    Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
    Norling LV; Ly L; Dalli J
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
    Norling LV; Serhan CN
    J Intern Med; 2010 Jul; 268(1):15-24. PubMed ID: 20497301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
    Chiang N; Serhan CN
    Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and proresolving lipid mediators.
    Serhan CN; Yacoubian S; Yang R
    Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
    Seki H; Tani Y; Arita M
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.